John B Green - Net Worth and Insider Trading
John B Green Net Worth
The estimated net worth of John B Green is at least $743,184 dollars as of 2024-11-13. John B Green is the CFO of Dicerna Pharmaceuticals Inc and owns about 19,421 shares of Dicerna Pharmaceuticals Inc (DRNA) stock worth over $742,271. John B Green is also the CFO of Verastem Inc and owns about 208 shares of Verastem Inc (VSTM) stock worth over $913. Details can be seen in John B Green's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John B Green has not made any transactions after 2020-04-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John B Green
John B Green Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John B Green owns 2 companies in total, including Dicerna Pharmaceuticals Inc (DRNA) , and Verastem Inc (VSTM) .
Click here to see the complete history of John B Green’s form 4 insider trades.
Insider Ownership Summary of John B Green
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DRNA | Dicerna Pharmaceuticals Inc | 2020-04-20 | Chief Financial Officer |
| VSTM | Verastem Inc | 2015-06-29 | Chief Financial Officer |
John B Green Latest Holdings Summary
John B Green currently owns a total of 2 stocks. Among these stocks, John B Green owns 19,421 shares of Dicerna Pharmaceuticals Inc (DRNA) as of April 20, 2020, with a value of $742,271 and a weighting of 99.88%. John B Green also owns 208 shares of Verastem Inc (VSTM) as of June 29, 2015, with a value of $913 and a weighting of 0.12%.
Latest Holdings of John B Green
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DRNA | Dicerna Pharmaceuticals Inc | 2020-04-20 | 19,421 | 38.22 | 742,271 |
| VSTM | Verastem Inc | 2015-06-29 | 208 | 4.39 | 913 |
Holding Weightings of John B Green
John B Green Form 4 Trading Tracker
According to the SEC Form 4 filings, John B Green has made a total of 5 transactions in Dicerna Pharmaceuticals Inc (DRNA) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Dicerna Pharmaceuticals Inc is the sale of 25,624 shares on April 20, 2020, which brought John B Green around $588,071.
According to the SEC Form 4 filings, John B Green has made a total of 0 transactions in Verastem Inc (VSTM) over the past 5 years. The most-recent trade in Verastem Inc is the acquisition of 42 shares on June 29, 2015, which cost John B Green around $3,560.
Insider Trading History of John B Green
- 1
John B Green Trading Performance
GuruFocus tracks the stock performance after each of John B Green's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John B Green is -48.14%. GuruFocus also compares John B Green's trading performance to market benchmark return within the same time period. The performance of stocks bought by John B Green within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John B Green's insider trading performs compared to the benchmark.
Performance of John B Green
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.43 | | | | | |
| Relative Return to S&P 500(%) | 1.71 | | | | | |
John B Green Ownership Network
Ownership Network List of John B Green
Ownership Network Relation of John B Green
John B Green Owned Company Details
What does Dicerna Pharmaceuticals Inc do?
Who are the key executives at Dicerna Pharmaceuticals Inc?
John B Green is the Chief Financial Officer of Dicerna Pharmaceuticals Inc. Other key executives at Dicerna Pharmaceuticals Inc include See Remarks Bob D Brown , EVP & Chief Medical Officer Shreeram Aradhye , and director & President and CEO Douglas Fambrough .
Dicerna Pharmaceuticals Inc (DRNA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc (DRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc (DRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Dicerna Pharmaceuticals Inc (DRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dicerna Pharmaceuticals Inc Insider Transactions
John B Green Mailing Address
Above is the net worth, insider trading, and ownership report for John B Green. You might contact John B Green via mailing address: C/o Dicerna Pharmaceuticals, Inc., 33 Hayden Avenue, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
